Semin Liver Dis 2019; 39(04): 442-451
DOI: 10.1055/s-0039-1688502
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Macrophages as a Cell-Based Therapy for Liver Disease

Philip J. Starkey Lewis*
1  MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
,
Francesca Moroni*
1  MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
,
Stuart J. Forbes
1  MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2019 (eFirst)

Abstract

Liver failure arising from acute and chronic liver disease is an unmet clinical need that urgently requires novel therapeutic options in addition to orthotopic liver transplantation. Cell therapies offer new strategies to recover liver function through the reconstitution of healthy parenchyma and resolution of tissue pathology. Macrophages are professional phagocytes that comprise a key part of the innate immune system providing an important defense mechanism against invading pathogens. Macrophages are an inherently diverse cell type with respect to ontogeny, tissue distribution, phenotype, and function. The ability of macrophages to afford innate immunity, efficiently scavenge apoptotic/necrotic cells, and modulate local tissue microenvironment makes them an attractive cell therapy candidate for various diseases. This review aims to outline the rationale and utility of macrophages to serve as a potential cell therapy for liver disease.

* Philip J. Starkey Lewis and Francesca Moroni have equal contribution.